155137-18-1 Usage
General Description
1-Benzyl-4,4-difluoropiperidine is an organic compound with the molecular formula C14H15F2N. It is a piperidine derivative that contains a benzyl group and two fluorine atoms attached to the piperidine ring. This chemical is often used as a building block in the synthesis of pharmaceuticals and agrochemicals, particularly in the development of new drugs and active ingredients. Its structure and properties make it a useful intermediate in organic chemistry, and it can be modified and functionalized to create a wide range of compounds with diverse biological activities. Additionally, it is important in the field of medicinal chemistry, where it is utilized in the development of potential drug candidates.
Check Digit Verification of cas no
The CAS Registry Mumber 155137-18-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,5,1,3 and 7 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 155137-18:
(8*1)+(7*5)+(6*5)+(5*1)+(4*3)+(3*7)+(2*1)+(1*8)=121
121 % 10 = 1
So 155137-18-1 is a valid CAS Registry Number.
155137-18-1Relevant articles and documents
Synthesis method of 4,4-difluoropiperidine-1-formyl chloride
-
Paragraph 0012; 0016; 0019, (2019/11/12)
The invention discloses a synthesis method of 4,4-difluoropiperidine-1-formyl chloride. The synthesis method comprises the following steps that first, a compound I, namely benzylpiperidin-4-one, and afluorine reagent are deoxidized and fluorated in a firs
ANTI-PULMONARY TUBERCULOSIS NITROIMIDAZOLE DERIVATIVE
-
Paragraph 0260-0262, (2017/12/31)
Disclosed is a substituted nitroimidazole derivative, which is mainly used for treating related diseases caused by mycobacterial infections, such as Mycobacterium tuberculosis, especially being suitable for diseases caused by resistant Mycobacterium tuberculosis.
PYRAZOLE DERIVATIVE
-
Page/Page column 41, (2010/11/27)
A compound represented by Formula (I): wherein Ar1 represents Formula (II): Ar2 represents a 5- or 6-membered aromatic heterocyclic group which may be substituted; and X represents Formula (III): a salt thereof, or a solvate of the compound or the salt. A potent platelet aggregation suppressant which does not inhibit COX-1 and COX-2 is provided.
